CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $150,000 | -85.6% | 4,429 | -90.1% | 0.00% | – |
| Q1 2021 | $1,045,000 | +2650.0% | 44,697 | +3278.5% | 0.00% | – |
| Q4 2020 | $38,000 | – | 1,323 | +16437.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 8 | -99.7% | 0.00% | – |
| Q1 2020 | $83,000 | -87.3% | 2,649 | -80.9% | 0.00% | – |
| Q4 2019 | $655,000 | +750.6% | 13,905 | +15.9% | 0.00% | – |
| Q3 2019 | $77,000 | +126.5% | 11,993 | +329.5% | 0.00% | – |
| Q2 2019 | $34,000 | +325.0% | 2,792 | +40.7% | 0.00% | – |
| Q4 2018 | $8,000 | -11.1% | 1,985 | +56.1% | 0.00% | – |
| Q3 2018 | $9,000 | – | 1,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |